e-learning
resources
Virtual 2020
Pre-Congress Content
Occupational and environmental causes of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial Lung Disease (ILD) in aluminium welders
J. Feary (London, United Kingdom), H. Parfrey (Cambridge, United Kingdom), S. Burge (Birmingham, United Kingdom), A. Nicholson (London, United Kingdom), A. Devaraj (London, United Kingdom), P. Cullinan (London, United Kingdom)
Source:
Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Session:
Occupational and environmental causes of respiratory disease
Session type:
E-poster session
Number:
3167
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Feary (London, United Kingdom), H. Parfrey (Cambridge, United Kingdom), S. Burge (Birmingham, United Kingdom), A. Nicholson (London, United Kingdom), A. Devaraj (London, United Kingdom), P. Cullinan (London, United Kingdom). Interstitial Lung Disease (ILD) in aluminium welders. 3167
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Unclassifiable Interstitial Lung Disease (ILD). Why?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Usefulness of pulsed cyclophosphamide in Interstitial Lung Disease (ILD)
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Inmunosuppresor therapy effectivness in Interstitial Lung Disease (ILD) associated Connective Tisuue Disease(CTD).
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Interstitial lung disease in welders
Source: Eur Respir Monogr 2020; 89: 238-251
Year: 2020
Tracking crackles of Interstitial Lung Disease during sleep.
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Evolution of an interstitial lung disease MDT: 5.5 years of data
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Usefulness of electronic nose in detection of Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Are normal lung sounds on aucultation associated with FEVI and FVC volume changes in Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Interstitial lung disease (ILD)?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019
Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD)
Source: International Congress 2014 – ILDs 5
Year: 2014
Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014
Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Pleural effusion in Niemann Pick Disease - associated Interstitial Lung Disease
Source: Virtual Congress 2020 – Interstitial lung diseases
Year: 2020
Transbronchial Lung Cryobiopsy (TBLC) for Interstitial Lung Disease (ILD) can be safely done in patients with multiple medical comorbidities
Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept